The 2nd Integrin-Targeted Drug Development Summit is your premier platform to network and connect with 60+ senior leaders specializing in Structural Biology, Clinical Development, and Pharmacology in Immuno-Oncology, Autoimmune, Fibrosis & Ophthalmology space, who are exploiting the clinical potential of integrin modulations.
This summit is your opportunity to demonstrate your expertise in the space and elevate your company’s standing and influence on the community in front of those developing drugs that aim to eradicate various diseases.
Our community is looking for expert leaders who specialize in:
- Computational biology and chemistry to help them accelerate drug screening and target engagement prediction
- PKPD and toxicology experts to give them guidance on translational and clinical modelling, optimizing dosing and scheduling for patients
- Biomarkers support and validation to identify patient population
- CROs for clinical development design and patient selection
Whether you need to communicate exciting progress to the decision-makers in the field, are looking to enhance or generate leads, or would like to get a grasp of next-generation investments in this market, you can rely on our ability to advise on and deliver the right solution for you.
Contact us today to learn how we can help you achieve your business goals faster, more effectively, and more cost-efficiently, at firstname.lastname@example.org